September: Prostate Cancer Awareness Month

For Prostate Cancer Awareness Month, we’ve put together risk, diagnosis and treatment information to help you better understand this condition. We’ve included a risk assessment tool, treatment guide and information about a free cancer answer line staffed by oncology nurses who can answer your questions.   Explore Health Hub Prostate Cancer Prevention: Checking Out the … Read More

Prostate Cancer Prevention: Checking Out the Hype

A healthy lifestyle can reduce our risks of developing chronic health problems, including some cancers. Men who want to improve their odds of avoiding prostate cancer may be interested in trying dietary supplements and vitamins.   Cleveland Clinic Glickman Urology & Kidney Institute Chairman Eric Klein, MD, weighs in on eight things believed to prevent … Read More

Prostate Cancer Screening: When Should You Be Tested?

For a lot of men, entering middle age used to be fairly straightforward when it came to their health: 1. Eat less, exercise more. 2. Get a colonoscopy. 3. Schedule your first prostate cancer screening. Recently, things got a bit muddled when a group of doctors recommended against the popular prostate-specific antigen (PSA) test which … Read More

A Spotlight for Detecting Cancer

Could finding cancer be as simple as flipping a switch? For the most fatal form of bladder cancer, it may be. With funding from the pharmaceutical company Photocure, J. Stephen Jones, MD, Chairman of the Department of Regional Urology at Cleveland Clinic’s Glickman Urological & Kidney Institute, and a multicenter team have found a way … Read More

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Double-Check for Prostate Cancer

Prostate cancer is a common but exceedingly treatable cancer if caught early. This year, 17 percent of American men — about 1 in 5 — will be diagnosed with prostate cancer. Fortunately, less than 3 percent of them will die of the disease. One of several reasons for this exceptional success rate is the prostate-specific … Read More